Contact Us

The choice depends on whether you are studying FTL (ferritin light chain)'s role as a component of the cytosolic ferritin iron storage complex or modeling neuroferritinopathy and FTL-related iron metabolism disorders. The Knockout line is the standard tool for asking whether FTL is required for these processes — FTL combines with FTH1 (ferritin heavy chain) to form the 24-subunit ferritin holoenzyme that stores up to 4500 iron atoms per molecule as ferric oxyhydroxide; FTH1 provides ferroxidase activity while FTL contributes to nucleation and iron storage. Overexpression is useful for studying FTL gain-of-function effects. For iron metabolism research, the EDITGENE FTL Knockout in HAP1 enables study of ferritin biology. FTL mutations (typically C-terminal frameshift/insertion mutations) cause neuroferritinopathy (autosomal dominant adult-onset basal ganglia disease with iron accumulation in brain); biallelic FTL loss causes hyperferritinemia-cataract syndrome with cataract. Rescue with wild-type or disease-associated FTL mutations enables genotype-function studies. The knockout is valuable for studying iron storage biology, ferritinophagy (NCOA4-mediated ferritin degradation), and emerging ferritin-targeted therapeutic approaches.

Yes. FTL rescue experiments require attention to ferritin holoenzyme assembly: • Construct design: use a codon-modified FTL sequence with a small C-terminal tag (FLAG, HA). FTL has 5'-UTR IRE (iron-responsive element) for translational regulation, mature protein with iron-binding residues — preserve all elements. • FTH1 partnership: FTL combines with FTH1 in a 24-subunit holoenzyme — rescue interpretation considers FTH1 expression and L/H subunit ratio. • Neuroferritinopathy mutation rescue: patient-derived FTL C-terminal frameshift/insertion mutations enable disease genotype-function studies. • Functional readout: rescue should restore ferritin holoenzyme assembly and cellular iron storage capacity. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying GSR (glutathione reductase)'s role as the principal recycler of oxidized glutathione (GSSG) back to reduced glutathione (GSH) or modeling glutathione-dependent redox biology. The Knockout line is the standard tool for asking whether GSR is required for these processes — GSR is a NADPH-dependent flavoprotein that reduces GSSG to GSH, maintaining the cellular GSH/GSSG ratio that is the principal cytosolic redox buffer; GSR loss results in GSSG accumulation and impaired glutathione-dependent antioxidant defense. Overexpression is useful for studying GSR in oxidative stress contexts. For redox biology research, the EDITGENE GSR Knockout in HAP1 enables study of glutathione recycling. Rescue with wild-type or catalytically-dead GSR is the standard specificity control. The knockout is valuable for studying ferroptosis (GSH-GPX4 axis), glutathione-dependent detoxification, and emerging GSR-targeted therapeutics — GSR inhibitors (carmustine, BCNU) have been explored for cancer chemosensitization.

Yes. GSR rescue experiments are well-established for redox biology research: • Construct design: use a codon-modified GSR sequence with a small C-terminal tag (FLAG, HA). GSR has FAD-binding domain, NADPH-binding domain, and dimerization domain — preserve all elements. • Catalytically-dead rescue: catalytic cysteine mutations or FAD-binding residue mutations abolish glutathione reductase activity and serve as the standard specificity control. • Mitochondrial vs cytosolic isoform rescue: GSR has cytosolic and mitochondrial isoforms (alternative translation initiation) — choose appropriate isoform. • Functional readout: rescue should restore cellular GSH/GSSG ratio and oxidative stress tolerance. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying EPHB3 (Eph receptor B3)'s role as a class B Eph family receptor tyrosine kinase or its functions in colorectal epithelial homeostasis. The Knockout line is the standard tool for asking whether EPHB3 is required for these processes — EPHB3 is a member of the EphB subfamily (EphB1-4, EphB6) that binds ephrin-B ligands at cell-cell contact sites, generating bidirectional signaling; EPHB3 is particularly important in colorectal epithelial crypt positioning (Eph-ephrin gradients control progenitor cell positioning along the crypt-villus axis). Overexpression is useful for studying EPHB3 gain-of-function effects. Important consideration: Eph family receptors share substantial substrate scope — single EPHB3 knockout may show modest phenotypes if other EphB receptors compensate. Rescue with wild-type or kinase-dead EPHB3 is the standard specificity control. The knockout is valuable for studying EphB-ephrinB bidirectional signaling, colorectal cancer biology (EPHB3 is a Wnt target and tumor suppressor in colorectal cancer initiation), and emerging Eph-targeted cancer therapeutics.

Yes. EPHB3 rescue experiments require attention to Eph receptor architecture: • Construct design: use a codon-modified EPHB3 sequence with a small intracellular C-terminal tag (FLAG, HA). EPHB3 has extracellular ligand-binding domain (LBD), cysteine-rich region, two fibronectin type III repeats, transmembrane span, juxtamembrane region, kinase domain, sterile alpha motif (SAM), and C-terminal PDZ-binding motif — preserve all elements. • Surface localization validation: confirm plasma membrane localization before ephrin-B binding studies. • Kinase-dead rescue: K665A mutation in the ATP-binding lysine abolishes catalytic activity. • Functional readout: rescue should restore ephrin-B-induced phospho-EPHB3 and downstream signaling. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying GRK6's role as a GPCR kinase phosphorylating activated GPCRs for desensitization or its emerging functions in cancer biology. The Knockout line is the standard tool for asking whether GRK6 is required for these processes — GRK6 (and GRK4, GRK5) constitute the membrane-anchored GRK4 subfamily that phosphorylates activated GPCRs (especially CXCR4, opioid receptors), promoting β-arrestin recruitment, receptor internalization, and desensitization. Overexpression is useful for studying GRK6 gain-of-function effects. Important consideration: GRK family (GRK1-7) members share substantial substrate scope — single GRK6 knockout may show modest phenotypes if other GRKs compensate. This product complements the parallel GRK5 Knockout in HAP1 (also available) for GRK4-subfamily functional dissection. Rescue with wild-type or kinase-dead GRK6 is the standard specificity control. The knockout is valuable for studying GPCR desensitization biology and emerging GRK6 cancer roles.

Yes. GRK6 rescue experiments require attention to membrane anchoring: • Construct design: use a codon-modified GRK6 sequence with a small C-terminal tag (FLAG, HA). GRK6 has N-terminal RGS-like domain, central kinase domain, and C-terminal palmitoylation sites (membrane anchoring) — preserve all elements. • Kinase-dead rescue: K215R mutation in the ATP-binding lysine abolishes catalytic activity. • Membrane-anchoring-deficient rescue: C-terminal palmitoylation site mutations abolish membrane localization, generating cytosolic GRK6. • Functional readout: rescue should restore CXCR4 and other GRK6-substrate GPCR phosphorylation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying HDAC10's role as a class IIb HDAC or its emerging functions as a polyamine deacetylase. The Knockout line is the standard tool for asking whether HDAC10 is required for these processes — HDAC10 is a class IIb HDAC (with HDAC6) but uniquely among HDACs functions as a polyamine deacetylase (N8-acetylspermidine to spermidine), with relatively limited histone deacetylase activity; HDAC10 has emerged as critical for autophagy regulation in tumor cells. Overexpression is useful for studying HDAC10 gain-of-function effects. For polyamine biology and autophagy research, the EDITGENE HDAC10 Knockout in HAP1 is highly informative — HDAC10's polyamine deacetylase activity is functionally distinct from canonical HDAC histone deacetylase activity. Rescue with wild-type or polyamine-deacetylase-deficient HDAC10 enables structure-function studies. The knockout is a critical specificity tool for HDAC10-selective inhibitors and pan-HDAC inhibitors (vorinostat, romidepsin, panobinostat) — HDAC10 inhibition has been characterized as supporting autophagy-mediated cancer cell sensitization to chemotherapy.

Yes. HDAC10 rescue experiments require attention to class IIb polyamine deacetylase architecture: • Construct design: use a codon-modified HDAC10 sequence with a small C-terminal tag (FLAG, HA). HDAC10 has N-terminal catalytic domain (polyamine deacetylase) and C-terminal leucine-rich domain (truncated catalytic-like, no activity) — preserve all elements. • Polyamine-deacetylase-deficient rescue: catalytic residue mutations in the N-terminal domain abolish N8-acetylspermidine deacetylation and serve as the standard specificity control. • Functional readout: rescue should restore polyamine metabolism (spermidine vs N8-acetylspermidine ratio) and autophagy regulation. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying GPBAR1 (TGR5, M-BAR)'s role as the principal bile acid-sensing GPCR or its emerging functions in neural and metabolic biology. The Knockout line is the standard tool for asking whether TGR5 is required for these processes — GPBAR1/TGR5 is a Gs-coupled seven-transmembrane receptor activated by bile acids (particularly lithocholic acid, taurolithocholic acid, deoxycholic acid), with established roles in energy metabolism, glucose homeostasis, and emerging functions in cancer and CNS biology. Overexpression is useful for studying TGR5 in heterologous expression contexts. For TGR5 research, the EDITGENE GPBAR1 Knockout in SK-N-AS enables study of TGR5 biology — SK-N-AS is a non-MYCN-amplified neuroblastoma cell line providing a neural-derived background. Rescue with wild-type or signaling-deficient TGR5 enables structure-function studies. The knockout is a critical specificity control for TGR5 agonists (INT-777, cilofexor for cholestatic liver disease, semaglutide-related bile acid pharmacology) and emerging TGR5-targeted metabolic disease therapeutics.

Yes. TGR5 rescue experiments require attention to bile acid binding: • Construct design: use a codon-modified GPBAR1 sequence with a small intracellular C-terminal tag (FLAG, HA). GPBAR1 is a seven-transmembrane Gs-coupled GPCR — preserve bile acid-binding pocket. • Signaling-deficient rescue: DRY motif mutations disrupt Gs-coupling. • Functional readout: rescue should restore bile acid-induced cAMP elevation and downstream PKA signaling. SK-N-AS-specific considerations: • SK-N-AS is a human neuroblastoma cell line (non-MYCN-amplified, derived from bone marrow metastasis) — a relevant model for non-MYCN-amplified neuroblastoma biology. • Lentiviral transduction is supported with moderate efficiency. • SK-N-AS provides a neural-derived background distinct from MYCN-amplified neuroblastoma lines.

The choice depends on whether you are studying DHX9 (DEAH-box helicase 9, RNA helicase A)'s role as a multifunctional RNA/DNA helicase or modeling its emerging functions as a cancer therapeutic target. The Knockout line is the standard tool for asking whether DHX9 is required for these processes — DHX9 is a DEAH-box ATP-dependent RNA/DNA helicase with diverse roles in transcription, splicing, translation, R-loop resolution, and Alu element repeat regulation; DHX9 has emerged as a cancer therapeutic target, particularly in microsatellite instability-high (MSI-H) cancers where DHX9 inhibition causes synthetic lethal R-loop accumulation. Overexpression is useful for studying DHX9 in heterologous expression contexts. For DHX9 research, the EDITGENE DHX9 Knockout in HEK293T is a workhorse mechanistic platform — HEK293T's very high transfection efficiency supports systematic structure-function studies. Rescue with wild-type or ATPase-dead DHX9 (K417R Walker A motif) is the standard specificity control. The knockout is a critical specificity tool for emerging DHX9 inhibitors (in preclinical development for MSI-H cancers and other contexts) — DHX9 has been characterized as one of the most promising new cancer drug targets in the synthetic lethal/R-loop biology space.

Yes. DHX9 rescue experiments are well-established for helicase research: • Construct design: use a codon-modified DHX9 sequence with a small C-terminal tag (FLAG, HA). DHX9 has dsRBD1, dsRBD2 (double-stranded RNA binding), DEAH-box helicase core, RGG/RGG-box, and OB-fold — preserve all elements. • ATPase-dead rescue: K417R mutation in the Walker A motif abolishes ATPase activity and serves as the standard specificity control. • Helicase-dead rescue: DEAH-box motif II mutations abolish helicase activity while retaining ATP binding. • Functional readout: rescue should restore R-loop resolution measured by S9.6 antibody imaging and DRIP-seq analysis. HEK293T transduces with very high efficiency and supports stable rescue line generation for systematic DHX9 mutation analysis.

The choice depends on whether you are studying GSK3B (glycogen synthase kinase 3β)'s role as a constitutively active serine/threonine kinase or its functions in Wnt signaling, insulin signaling, neurodegeneration, and lithium pharmacology. The Knockout line is the standard tool for asking whether GSK3β is required for these processes — GSK3β is a constitutively active kinase (atypically) that phosphorylates >100 substrates including β-catenin (Wnt pathway destruction complex), tau (AD pathology), glycogen synthase (insulin/glycogen metabolism), and many others; GSK3β is inhibited by PI3K-AKT-mediated S9 phosphorylation. Overexpression is useful for studying GSK3β gain-of-function effects. Important consideration: GSK3α (GSK3A) paralog expression analysis is essential given substantial functional overlap. Rescue with wild-type, kinase-dead, or S9A (constitutively active, non-inhibitable) GSK3β enables comprehensive structure-function studies. The knockout is a critical specificity control for lithium (the gold-standard mood stabilizer that directly inhibits GSK3β), tideglusib (clinical GSK3 inhibitor for AD and progressive supranuclear palsy), and emerging GSK3-targeted therapeutics in psychiatric and neurodegenerative disease.